Copied
 
 
2023, DKK
13.03.2024
Bruttoresultat
Na.
Primær drift
Na.
Årets resultat

0

Aktiver

50.000

Kortfristede aktiver

50.000

Egenkapital

50.000

Afkastningsgrad

0 %

Soliditetsgrad

100 %

Likviditetsgrad

0 %

Resultat
13.03.2024
Årsrapport
2023
13.03.2024
2022
08.03.2023
2021
23.05.2022
2020
21.05.2021
2019
01.07.2020
Nettoomsætning
Resultat af primær drift00000
Indtægter af kapitalandele (tilknyttede og associerede) 00000
Finansielle indtægter0366000
Finansieringsomkostninger00-36600
Andre finansielle omkostninger00000
Resultat før skat0366-36600
Resultat0366-36600
Forslag til udbytte00000
Aktiver
13.03.2024
Årsrapport
2023
13.03.2024
2022
08.03.2023
2021
23.05.2022
2020
21.05.2021
2019
01.07.2020
Kortfristede varebeholdninger00000
Kortfristede tilgodehavender fra salg og tjenesteydelser 000050.000
Likvider50.00050.00049.63450.0000
Kortfristede aktiver50.00050.00049.63450.00050.000
Immaterielle aktiver og goodwill00000
Finansielle anlægsaktiver00000
Materielle aktiver00000
Langfristede aktiver00000
Aktiver50.00050.00049.63450.00050.000
Aktiver
13.03.2024
Passiver
13.03.2024
Årsrapport
2023
13.03.2024
2022
08.03.2023
2021
23.05.2022
2020
21.05.2021
2019
01.07.2020
Forslag til udbytte00000
Egenkapital50.00050.00049.63450.00050.000
Hensatte forpligtelser00000
Langfristet gæld til banker00000
Anden langfristet gæld000
Leverandører af varer og tjenesteydelser00000
Kortfristede forpligtelser00000
Gældsforpligtelser00000
Forpligtelser00000
Passiver50.00050.00049.63450.00050.000
Passiver
13.03.2024
Nøgletal
13.03.2024
Årsrapport
2023
13.03.2024
2022
08.03.2023
2021
23.05.2022
2020
21.05.2021
2019
01.07.2020
Afkastningsgrad Na.Na.Na.Na.Na.
Dækningsgrad
Resultatgrad Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.
Egenkapitals-forretning Na.0,7 %-0,7 %Na.Na.
Payout-ratio Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal Na.Na.Na.Na.Na.
Soliditestgrad 100,0 %100,0 %100,0 %100,0 %100,0 %
Likviditetsgrad Na.Na.Na.Na.Na.
Resultat
13.03.2024
Gæld
13.03.2024
Årsrapport
13.03.2024
Nyeste:01.01.2023- 31.12.2023(offentliggjort: 13.03.2024)
Information om virksomhedens regnskabsklasse:The annual report of Pivotal Clinical ApS for 2023 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B.
Beretning
13.03.2024
Dato for ledelsens godkendelse af årsrapporten:2024-03-13
Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of Pivotal Clinical ApS for the financial year 1 January 2023 - 31 December 2023. The Annual Report is presented in accordance with the Danish Financial Statements Act. In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 January 2023 - 31 December 2023. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. The conditions for not conducting an audit of the Financial Statement have been met. We recommend that the Annual Report be adopted at the Annual General Meeting. Herlev, 13 March 2024 Executive Board Dr. Ibrahim Farr Manager
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of Pivotal Clinical ApS for the financial year 1 January 2023 - 31 December 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The Company's principal activities consist in Clinical Research services to the healthcare industry.